nach oben

Erschienen in:

18.01.2022 | Epidemiology

Prognosis of pregnancy-associated breast cancer: inferior outcome in patients diagnosed during second and third gestational trimesters and lactation

verfasst von: B. B. M. Suelmann, C. F. J. Bakhuis, C. van Dooijeweert, J. Verloop, R. Zweemer, S. Linn, E. van der Wall, P. J. van Diest

Erschienen in: Breast Cancer Research and Treatment | Ausgabe 1/2022

Einloggen, um Zugang zu erhalten

Abstract

Purpose

Pregnancy-associated breast cancer, although most commonly defined as breast cancer diagnosed during pregnancy or ≤1 year following delivery, knows a variety of definitions, likely related to the diversity of reported clinicopathological features and prognosis. More insight into the different breast cancer subgroups during pregnancy, time after delivery and the postpartum period is therefore warranted.

Methods

Patients with breast cancer diagnosed during pregnancy or ≤6 months postdelivery were included, and subdivided according to gestational trimester, and postpartum patients according to lactational status. Subgroups were compared to matched non-PABC patients, to investigate the influence of pregnancy and lactation on clinical course and outcome.

Results

Overall, 662 PABC patients were included (median age 34 years, median follow-up 6.5 years). PABC patients showed an advanced stage at diagnosis and an inferior 5-years-OS (75.4% vs. 83.2%, p = 0.000) compared to 1392 matched non-PABC patients. In subgroup analysis, first trimester PABC patients showed a significantly lower tumor size and stage as compared to other trimesters. Patients diagnosed during the first trimester and postpartum non-lactating patients had a relatively good OS (81.3% and 77.9%, respectively) versus patients diagnosed during the second and third trimesters and during lactation (OS 60.0%, 64.9% and 65.6%, respectively, p = 0.003).

Conclusion

In this large (uniquely specified) PABC cohort, an inferior outcome was found for patients diagnosed within the second and third gestational trimesters and during lactation. These findings indicate that PABC is clinically a heterogeneous group of breast cancer patients that should be redefined based on trimester of diagnosis and lactational status.

Bray F, Ferlay J, Soerjomataram J, Siegel RL, Torre LA, Jemal A (2018) Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin 68(6):394–424CrossRef

Stensheim H, Moller B, van Dijk T, Fossa SD (2009) Cause-specific survival for women diagnosed with cancer during pregnancy or lactation: a registry-based cohort study. J Clin Oncol 27:45–51CrossRef

Parazzini F, Franchi M, Tavani A, Negri E, Peccatori FA (2017) Frequency of pregnancy related cancer: a population based linkage study in Lombardy. Italy Int J Gynecol Cancer 27:613–619CrossRef

Van Calsteren K, Heys L, De Smet F et al (2010) Cancer during pregnacy: an analysis of 215 patients emphazing the obstetrical and the neonatal outcomes. J Clin Oncol 28:683–689CrossRef

Trichopoulos D, Hsieh CC, MacMahon B, Lin TM, Lowe CR, Mirra AP, Ravnihar B, Salber EJ, Valaoras VG, Yuasa S (1983) Age at any birth and breast cancer risk. Int J Cancer 31(6):701–704CrossRef

Vatten LJ, Romundstad PR, Trichopoulos D, Skjaerven R (2002) Pregnancy related protection against breast cancer depends on length of gestation. Br J Cancer 87(3):289–290CrossRef

Husby A, Wohlfahrt J, Øyen N, Melbye M (2018) Pregnancy duration and breast cancer risk. Nat Commun 9:4255CrossRef

Liu Q, Wuu J, Lambe M, Hsieh SF, Ekbom A, Hsieh CC (2002) Transient increase in breast cancer risk after giving birth: postpartum period with the highest risk (Sweden). Cancer Causes Control 13(4):299–305CrossRef

Nichols HB, Schoemaker MJ, Cai J et al (2019) Breast cancer risk after recent childbirth: a pooled analysis of 15 prospective studies. Ann Intern Med 170(1):22–30CrossRef

10.

Wohlfahrt J, Andersen PK, Mouridsen HT, Melbye M (2001) Risk of late-stage breast cancer after a childbirth. Am J Epidemiol 153(11):1079–1084CrossRef

11.

Lyons TR, Schedin PJ, Borges VF (2009) Pregnancy and breast cancer: when they collide. J Mammary Gland Biol Neoplasia 14(2):87–98. https://doi.org/10.1007/s10911-009-9119-7CrossRefPubMedPubMedCentral

12.

Johansson AL, Andersson TM, Hsieh CC, Jirström K, Dickman P, Cnattingius S, Lambe M (2013) Stage at diagnosis and mortality in women with pregnancy-associated breast cancer (PABC). Breast Cancer Res Treat 139(1):183–192CrossRef

13.

Bajpai J, Simha V, Shylasree TS, Sarin R, Pathak R, Popat P, Mokal S, Dandekar S, Bhansal V, Ghosh J, Nair N, Gulia S, Rath S, Joshi S, Wadasadawala T, Sheth T, Parmar V, Banavali SD, Badwe RA, Gupta S (2021) Pregnancy associated breast cancer (PABC): report from a gestational cancer registry from a tertiary cancer care centre. India Breast 56:88–95CrossRef

14.

Bae SY, Kim SJ, Lee J, Lee ES, Kim EK, Park HY, Suh YJ, Kim HK, You JY, Jung SP (2018) Clinical subtypes and prognosis of pregnancy-associated breast cancer: results from the Korean Breast Cancer Society Registry database. Breast Cancer Res Treat 172(1):113–121CrossRef

15.

Rodriguez AO, Chew H, Cress R, Xing G, McElvy S, Danielsen B, Smith L (2008) Evidence of poorer survival in pregnancy-associated breast cancer. Obstet Gynecol 112(1):71–78CrossRef

16.

Madaras L, Kovács KA, Szász AM, Kenessey I, Tőkés AM, Székely B, Baranyák Z, Kiss O, Dank M, Kulka J (2014) Clinicopathological features and prognosis of pregnancy associated breast cancer - a matched case control study. Pathol Oncol Res 20(3):581–590CrossRef

17.

Stensheim H, Møller B, van Dijk T, Fosså SD (2009) Cause-specific survival for women diagnosed with cancer during pregnancy or lactation: a registry-based cohort study. J Clin Oncol 27(1):45–51CrossRef

18.

Langer A, Mohallem M, Stevens D, Rouzier R, Lerebours F, Chérel P (2014) A single-institution study of 117 pregnancy-associated breast cancers (PABC): presentation, imaging, clinicopathological data and outcome. Diagn Interv Imaging 95(4):435–441CrossRef

19.

Suelmann BBM, van Dooijeweert C, van der Wall E, Linn S, van Diest PJ (2021) Pregnancy-associated breast cancer: nationwide Dutch study confirms a discriminatory aggressive histopathologic profile. Breast Cancer Res Treat 186(3):699–704CrossRef

20.

Shao C, Yu Z, Xiao J, Liu L, Hong F, Zhang Y, Jia H (2020) Prognosis of pregnancy-associated breast cancer: a meta-analysis. BMC Cancer 20(1):746CrossRef

21.

Iqbal J, Amir E, Rochon PA, Giannakeas V, Sun P, Narod SA (2017) Association of the timing of pregnancy with survival in women with breast cancer. JAMA Oncol 3(5):659–665CrossRef

22.

Ploquin A, Pistilli B, Tresch E, Frenel JS, Lerebours F, Lesur A, Loustalot C, Bachelot T, Provansal M, Ferrero JM, Coussy F, Debled M, Kerbrat P, Vinceneux A, Allouache D, Morvan F, Dalenc F, Guiu S, Rouzier R, Vanlemmens L (2018) 5-year overall survival after early breast cancer diagnosed during pregnancy: a retrospective case-control multicentre French study. Eur J Cancer 95:30–37CrossRef

23.

Boudy AS, Naoura I, Selleret L, Zilberman S, Gligorov J, Richard S, Thomassin-Naggara I, Chabbert-Buffet N, Ballester M, Bendifallah S, Darai E (2018) Propensity score to evaluate prognosis in pregnancy-associated breast cancer: analysis from a French cancer network. Breast 40:10–15CrossRef

24.

Amant F, von Minckwitz G, Han SN, Bontenbal M, Ring AE, Giermek J, Wildiers H, Fehm T, Linn SC, Schlehe B, Neven P, Westenend PJ, Müller V, Van Calsteren K, Rack B, Nekljudova V, Harbeck N, Untch M, Witteveen PO, Schwedler K, Thomssen C, Van Calster B, Loibl S (2013) Prognosis of women with primary breast cancer diagnosed during pregnancy: results from an international collaborative study. J Clin Oncol 31(20):2532–2539CrossRef

25.

Choi M, Han J, Yang BR, Jang MJ, Kim M, Kim TY, Im SA, Lee HB, Moon HG, Han W, Noh DY, Lee KH (2019) Prognostic impact of pregnancy in Korean patients with breast cancer. Oncologist 24(12)

26.

Ibrahim EM, Ezzat AA, Baloush A, Hussain ZH, Mohammed GH (2000) Pregnancy-associated breast cancer: a case-control study in a young population with a high-fertility rate. Med Oncol 17(4):293–300CrossRef

27.

Murphy CG, Mallam D, Stein S, Patil S, Howard J, Sklarin N, Hudis CA, Gemignani ML, Seidman AD (2012) Current or recent pregnancy is associated with adverse pathologic features but not impaired survival in early breast cancer. Cancer 118(13):3254–3259CrossRef

28.

Suelmann BBM, Dooijeweert van C, Bakhuis CFJ, Linn S, Wall van der W, Diest van PJ, Pregnancy associated breast cancer: the influence of gestational age on the histopathologic profile, submitted

29.

Foundation PALGA, Annual report (2017) https://www.palga.nl/assets/uploads/Jaarverslag/Jaarverslag_2017_websiteversie.pdf

30.

Casparie M, Tiebosch AT, Burger G, Blauwgeers H, van de Pol A, van Krieken JH, Meijer GA (2007) Pathology databanking and biobanking in The Netherlands, a central role for PALGA, the nationwide histopathology and cytopathology data network and archive. Cell Oncol 29(1):19–24PubMedPubMedCentral

31.

Halaska MJ, Pentheroudakis G, Strnad P et al (2009) Presentation, management and outcome of 32 patients with pregnancy-associated breast cancer: a matched controlled study. Breast J 15:461–467CrossRef

32.

Lethaby AE, O’Neill MA, Mason BH, Holdaway IM, Harvey VJ (1996) Overall survival from breast cancer in women pregnant or lactating at or after diagnosis. Auckland Breast Cancer Study Group. Int J Cancer 67(6):751–5CrossRef

33.

Anderson BO, Petrek JA, Byrd DR, Senie RT, Borgen PI (1996) Pregnancy influences breast cancer stage at diagnosis in women 30 years of age and younger. Ann Surg Oncol 3(2):204–211CrossRef

34.

Bonnier P, Romain S, Dilhuydy JM et al (1997) Influence of pregnancy on the outcome of breast cancer: a case-control study Societe Francaise de Senologie et de Pathologie Mammaire Study Group. Int J Cancer. 72:720–727CrossRef

35.

Mathelin C, Annane K, Treisser A et al (2008) Pregnancy and post-partum breast cancer: a prospective study. Anticancer Res 28:2447–2452PubMed

36.

Dimitrakakis C, Zagouri F, Tsigginou A, Marinopoulos S, Sergentanis TN, Keramopoulos A, Zografos GC, Ampela K, Mpaltas D, Papadimitriou C, Dimopoulos MA, Antsaklis A (2013) Does pregnancy-associated breast cancer imply a worse prognosis? a matched case-case study. Breast Care (Basel) 8(3):203–207CrossRef

37.

Azim HA Jr, Santoro L, Russell-Edu W, Pentheroudakis G, Pavlidis N, Peccatori FA (2012) Prognosis of pregnancy-associated breast cancer: a meta-analysis of 30 studies. Cancer Treat Rev 38(7):834–842CrossRef

38.

Peterson NB, Huang Y, Newcomb PA, Titus-Ernstoff L, Trentham-Dietz A, Anic G, Egan KM (2008) Childbearing recency and modifiers of premenopausal breast cancer risk. Cancer Epidemiol Biomarkers Prev 17(11):3284–3287CrossRef

39.

Tworoger SS, Hankinson SE (2006) Prolactin and breast cancer risk. Cancer Lett 243(2):160–169CrossRef

40.

Clevenger CV (2003) Role of prolactin/prolactin receptor signaling in human breast cancer. Breast Dis 18:75–86CrossRef

Titel: Prognosis of pregnancy-associated breast cancer: inferior outcome in patients diagnosed during second and third gestational trimesters and lactation
verfasst von: B. B. M. Suelmann
C. F. J. Bakhuis
C. van Dooijeweert
J. Verloop
R. Zweemer
S. Linn
E. van der Wall
P. J. van Diest
Publikationsdatum: 18.01.2022
Verlag: Springer US
Erschienen in: Breast Cancer Research and Treatment / Ausgabe 1/2022
Print ISSN: 0167-6806
Elektronische ISSN: 1573-7217
DOI: https://doi.org/10.1007/s10549-021-06471-6

Update Onkologie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.

Newsletter bestellen

Live-Webinar "Urologie und Sexualmedizin in der Praxis"

Springer Medizin

Prognosis of pregnancy-associated breast cancer: inferior outcome in patients diagnosed during second and third gestational trimesters and lactation